sFlt-1, Coagulation Function, and Platelets as Predictors of Preeclampsia
Authors:
Open Access
- 29 January 2025
- journal article
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 47 (3) , 102772
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testingAmerican Journal of Obstetrics and Gynecology, 2024
- Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and ManagementJournal of Obstetrics and Gynaecology Canada, 2022
- Preeclampsia—Pathophysiology and Clinical PresentationsJACC, 2020
- The competing risk approach for prediction of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2020
- Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trialsClinical Nutrition, 2020
- Diagnostic accuracy of first‐trimester combined screening for early‐onset and preterm pre‐eclampsia at 8–10 compared with 11–13 weeks' gestationUltrasound in Obstetrics & Gynecology, 2020
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of VietnamPregnancy Hypertension, 2018
- Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic reviewPregnancy Hypertension, 2018
- Reference Intervals of Routine Coagulation Assays During the Pregnancy and Puerperium PeriodJournal of Clinical Laboratory Analysis, 2016